BioXcel Therapeutics, Inc.: capex
| Value | {"amount": 139000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-06-30 |
| Status | current |
| Entity | BioXcel Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:36:07.356361+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/056c1130-0449-44e7-a3d6-10bf8b55bc69
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-013353Retrieved: 2026-08-19T17:36:07.356361+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001720893/capex/2022-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/056c1130-0449-44e7-a3d6-10bf8b55bc69
History
- no predecessors — first report